Structure Therapeutics, Inc. Sponsored ADR ( (GPCR) ) has released its Q3 earnings. Here is a breakdown of the information Structure ...

“We are in a period of great momentum and execution at Structure Therapeutics ... profile of GSBR-1290 as a potential best-in-class oral small molecule GLP-1 receptor (GLP1-R) agonist. We also plan to ...

Scientists at the University of Copenhagen have discovered a new weight loss drug target that reduces appetite, increases energy expenditure, and improves insulin sensitivity without causing nausea or ...

Over the past three decades, there has been a startling increase in the prevalence of obesity across the U.S., at least ...

We actually call these GLP-1 patients GLP-1 orphans ... we really evaluated the entire structure across all departments and we looked at ways to gain efficiency and work towards profitability at the ...

Thank you for standing by. My name is John, and I’ll be your conference operator today. At this time I would like to welcome everyone to the Allurion Third Quarter Earnings Call. All lines have been ...

Q3 2024 Earnings Call Transcript November 8, 2024 Operator: Ladies and gentlemen, good morning, and welcome to the Apyx ...

Good morning, and welcome to the Wave Life Sciences Third Quarter 2024 Financial Results Conference Call. At this time, all participants are in a listen only mode. As a reminder, this call is being ...

Nearly three quarters of U.S. adults are overweight or obese, according to a sweeping new study. The findings have ...

Allurion Technologies Inc (ALUR) reports significant growth in recurring revenue and strategic restructuring, despite facing market headwinds and product recalls.

Kantar, the world's leading marketing data and analytics company, today released its Who Cares Who Does: Decoding Wellness report on global wellness trends.